Modification of the tumor response threshold in patients of advanced non-small cell lung cancer treated with chemotherapy plus targeted agents: a pooled study from five clinical trials in one institution
Annals of Translational Medicine, 2019.
Non-small cell lung cancer (NSCLC)Response Evaluation Criteria in Solid Tumors (RECIST)X-tileoptimal thresholdtumor shrinkage
A 10.0% tumor shrinkage in the SLD indicated an indicative efficacy evaluation threshold for NSCLC patients treated with chemotherapy plus targeted agents.
Full Text (Upload PDF)
PPT (Upload PPT)